DAFNA Capital Management LLC lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 1.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 397,505 shares of the exchange traded fund’s stock after selling 4,000 shares during the quarter. SPDR S&P Biotech ETF comprises about 9.1% of DAFNA Capital Management LLC’s holdings, making the stock its largest position. DAFNA Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $35,799,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the stock. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $29,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $29,000. Avior Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares in the last quarter. Lee Danner & Bass Inc. acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $38,000. Finally, Bank of Jackson Hole Trust purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $43,000.
SPDR S&P Biotech ETF Price Performance
NYSEARCA:XBI opened at $77.35 on Thursday. The firm has a 50-day moving average of $81.12 and a two-hundred day moving average of $89.56. The stock has a market cap of $4.91 billion, a P/E ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Calculate Options Profits
- DexCom Stock: Earnings Beat and New Market Access Drive Bull Case
- Best Stocks Under $5.00
- Uber’s Earnings Offer Clues on the Stock and Broader Economy
- Quiet Period Expirations Explained
- Institutions Skipped the Rally: Where the Money Went
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.